Imraldi 40 mg/0.8 ml, Injektionslösung in einer Fertigspritze
7680674270010
CH-67427
L04AB04
07.15.0.
Active substances:
1 / 3
google
Details
- Product number
- 6742701
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- adalimumabum 40 mg, natrii citras dihydricus, acidum citricum monohydricum, histidinum, histidini hydrochloridum monohydricum, sorbitolum 20 mg, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml corresp. natrium 0.375 mg.
Articles (1)
Imraldi 40 mg/0.8 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
adalimumabum
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii citras dihydricus
|
- | Substance | HNIDK |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
sorbitolum
|
20.0 MG | Substance | HBESI |
|
polysorbatum 20
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
0.375 MG | Substance | HBESI |
Authorization holder
Samsung Bioepis CH GmbH
6005 Luzern
Authorization information
- Swissmedic authorization number
- 67427
- Drug name
- Imraldi, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L04AB04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 03/04/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- IMRALDI sol inj 40 mg/0.8ml ser préremp 0.8 ml
- Description (DE)
- IMRALDI Inj Lös 40 mg/0.8ml Fertigspr 0.8 ml
- Market launch
- 03/04/2020
- Market withdrawal
- 11/05/2026
- Narcotic (BTM)
- No